Premium
Clinical features of prostate cancer patients younger than 50 years: Report of seven cases
Author(s) -
Kanto Satoru,
Ohyama Chikara,
Okada Yasuhiro,
MitSukawa Shiro,
Takemoto Jun,
Hoshi Senji,
Orikasa Seiichi
Publication year - 2002
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1046/j.1442-2042.2002.00427.x
Subject(s) - medicine , prostatectomy , prostate cancer , rectal examination , stage (stratigraphy) , cancer , occult , incidence (geometry) , prostate , urology , adenocarcinoma , prostate specific antigen , gynecology , pathology , paleontology , physics , alternative medicine , optics , biology
Background: The incidence of prostate cancer increases with age and latent cancer is common in older men. But clinical prostate cancer is rare in men aged < 50 years.Methods: Between 1988 and 2000, we studied seven cases of prostate cancer in men aged under 50 years. The clinicopathological results included: the first sign or symptom; prostate‐specific antigen (PSA) at the time of diagnosis; existence of abnormal digital rectal examination (DRE); the differentiation of the cancer and Gleason score; and the outcome of treatment.Results: Six cases were diagnosed as stage D2. One case was diagnosed as stage B2 and the patient underwent radical prostatectomy. None of the cases were detected by mass screening. The PSA at diagnosis was < 10 ng/mL in only one case and that patient underwent radical prostatectomy. Six cases were diagnosed pathologically as poorly differentiated adenocarcinoma. The only patient who survived more than 5 years underwent radical prostatectomy.Conclusion: Six of seven cases of prostate cancer were detected at advanced stage. Only one case was thought to be curable and this patient’s cancer was detected by chance occult blood test. Because young prostate cancer patients are potential candidates for radical prostatectomy and the sensitivity of PSA might be higher in young men, high‐risk groups could be screened by PSA.